Transcription factor antibodies are the least forgiving reagents in a catalogue: the protein is nuclear, scarce, often short lived and frequently one of several family members with the same domains. So the evidence that matters is genetic rather than a pretty blot, and the sample has to be a nuclear extract or a section rather than a whole cell lysate that dilutes the compartment away.
A zeb2 antibody and a fra1 antibody on the EMT and AP-1 families
Both proteins live in families whose members share their DNA binding domains, so a clone raised against a conserved region reports the family. The mesenchymal factor is expressed at low abundance and induced transiently, which means a treated positive control rather than a cell line assumed to express it; the AP-1 component is one of several Fos proteins with similar mass, so specificity has to be shown against the relatives rather than asserted. Knockdown material beside wild type, in the application you will run, is what settles either.
A foxa1 antibody and a cebpb antibody on lineage and stress factors
Forkhead and CCAAT-enhancer binding proteins are read as lineage and differentiation markers, and both have isoforms produced from alternative translation starts that differ in function, so the immunogen's position decides whether one isoform or all of them are seen. For chromatin immunoprecipitation the reagent has to be qualified for pull down, since crosslinking changes the epitope. Nuclear extraction, a documented positive tissue and a counterstain are what make a nuclear stain believable.
A wnt5a antibody and a wnt3a antibody on secreted ligands
Wnt proteins are lipid modified, hydrophobic and secreted in tiny amounts, which makes them among the hardest antigens on a catalogue to detect honestly. In practice the ligand is measured in conditioned medium concentrated first, or in a cell lysate as the intracellular pool, and the detergent matters because the lipid modification keeps the protein on membranes. A positive control from an overexpressing line and a purified recombinant standard are both worth having, since an absent band here is usually the method rather than the biology.
A ror gamma antibody and an arnt antibody on nuclear receptors and partners
The retinoid-related receptor exists as two isoforms from different promoters, and the immune-relevant one is a truncated form, so a clone that recognises only the full length protein misses the population everybody studies. The aryl hydrocarbon nuclear translocator is a dimerisation partner rather than a sensor, present constitutively, which makes it the loading anchor in a pathway blot rather than the readout. For both, state the isoform and run a stimulated control where the pathway is the question.
Why nuclear extracts rather than whole cell lysates
A transcription factor may be a thousandth of the protein in a cell, and a whole cell lysate dilutes it below what a blot can see while adding abundant cytoplasmic bands that sit near the same mass. A nuclear extract raises the target several fold and gives a cleaner background, with a cytoplasmic fraction beside it to show the separation worked. Lamin or a histone in the nuclear lane and a cytoplasmic enzyme in the other are the controls that make the fractionation evidence rather than a claim.
Chromatin immunoprecipitation needs its own validation
An antibody validated on a blot has been shown to bind a denatured, membrane-bound epitope. Crosslinked chromatin presents something different, so a reagent for pull down has to be qualified for it specifically, ideally with a published enrichment at a known site and a negative region beside it. Lot matters more here than anywhere else, and the practical discipline is to buy a larger lot once a clone works and to record its number with the data.
Short half lives, and what handling costs
Many of these proteins are degraded within minutes of a change in signalling, so the abundance a blot reports is partly the handling: a plate left on the bench, a slow scrape, a lysate thawed twice. Harvest on ice with inhibitors in the buffer, and include a proteasome inhibited arm once so the antibody is shown to see the accumulated protein. Where a result depends on a fall in abundance, that arm is what separates degradation from a reagent that cannot see the protein at all.
What to ask for before ordering
Ask three things and read the datasheet for a fourth. Genetic validation in your application; the immunogen's position, which predicts isoform coverage; and the exact positive control the vendor's own figure used, with the treatment and time. The fourth is whether the clone has been used for chromatin work in the literature, because for this class the published record by clone is more informative than any catalogue claim.
Questions people ask about twist1 antibody
Why is a whole cell lysate the wrong sample?
It dilutes a nuclear protein below the blot's reach and adds abundant cytoplasmic bands nearby. Use a nuclear extract with a cytoplasmic fraction beside it.
Does a blot-validated clone work for ChIP?
Not on that evidence. Crosslinking changes the epitope, so the reagent has to be qualified for pull down.
Why do two clones disagree on the same factor?
Family members share DNA binding domains and most of these proteins have isoforms. The immunogen's position decides what is seen.